Slovenia’s Pharma company Krka inaugurated a EUR 85m plant
Slovenia’s Pharma company Krka inaugurated a EUR 85m plant
Slovenia’s Pharma company Krka inaugurated a EUR 85m plant for the production of active ingredients in Krško, in east of the country on Tuesday. The facility will enable it to control the whole process from the development to production of raw materials and end products.
The Sinteza 1 plant manufactures active ingredients for vertically integrated medicinal products, which represent 70% of the company’s range of sales, Krka chairman Jože Colarič told a news conference at the inauguration.
He said the plant would enable optimal production of strategically important active ingredients, thus enabling Krka to boost its competitive edge and its position in all its markets. It will enable it to offer generics in selected key markets first and to respond to regulatory change fast, Colarič said.
The 5,500 sq metre plant employs 61 staff, but Colarič announced an expansion with an even larger facility on the company’s 16.6 hectare location in Krško. The construction is slated to start in 2020 reports Slovenia Times
